Epidemiological Clinical Features and Evolution of Gastroduodenal Ulcer Bleeding in a Tertiary Care Hospital in Spain, during the Last Seven Years
Table 2
Differential clinical characteristics according to endoscopic findings.
Gastric ulcera ()
Duodenal ulcera ()
P
Male gender, n (%)
63 (62.4)
127 (77)
<0.05
Age (mean ± SD, years) Range
(26–97)
(19–99)
0.1
Comorbidities, n (%)
48 (47.5)
80 (48.5)
0.9
Drugsb, n (%)
69 (68.3)
82 (49.7)
<0.01
Prior peptic ulcer, n (%)
14 (13.9)
30 (18.2)
0.4
Forrest classification, n (%)
Active bleeding (Ia, Ib)
10 (9.9)
45 (27.3)
<0.001
Visible vessel (IIa)
28 (27.7)
29 (17.6)
Adherent clot (IIb)
17 (16.8)
29 (17.6)
Flat/Black spot (IIc)
20 (19.8)
22 (13.3)
<0.05c
White base (III)
26 (25.7)
40 (24.2)
0.9
Endoscopic treatment, n (%)
64 (63.4)
115 (69.7)
0.3
Patients with gastric and duodenal ulcers were not considered.
bAspirin, non-steroidal anti-inflammatory drugs (NSAID), antiplatelet therapy, and/or anticoagulant drugs.
cAll ulcers were classified as Forrest II.
